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Introduction
Antimicrobial resistance is increasing worldwide and is limiting the armamentarium of effective treatment options for many infectious diseases. Surveillance studies play a critical role in defining the extent of antimicrobial resistance. 1 Ideally, surveillance studies are designed to identify significant susceptibility shifts in a range of antimicrobials appropriate for the organisms under study, with results reported rapidly to a broad audience, thereby enabling the study to guide appropriate therapy. 2 The CANWARD study is an annual, ongoing surveillance study that has been conducted in Canada since 2007. CANWARD collects clinically significant organisms isolated from defined specimen sources (blood, respiratory, urine and wound cultures) from tertiary-care centres in Canada. 3 In contrast to surveillance studies with designated organisms of interest, the CANWARD study permits both an epidemiological assessment of the pathogen prevalence and the antimicrobial susceptibility of a large variety of organisms. A considerable amount of information has been collected in the 5 year study period, which has permitted investigation of the trends in antimicrobial resistance. As seen with other studies, 4 -7 many demographic factors were found to be associated with antimicrobial resistance in CANWARD. In particular, age was found to be significantly associated with differences in antimicrobial resistance for many organisms. The purpose of this study was to describe the association between age and antimicrobial resistance for the most commonly identified pathogens in CANWARD.
Materials and methods

Bacterial isolates
Between 2007 and 2011, 27123 clinically significant isolates were collected as part of the CANWARD surveillance study from tertiary-care centres across Canada. A detailed description of the CANWARD collection methods is published in this Supplement. 3 Briefly, consecutive isolates from varied specimen sources (blood cultures, respiratory, urine and wound specimens) that were deemed to be of clinical significance by the tertiary-care centres were submitted to the coordinating site (Health Sciences Centre, Winnipeg, Manitoba, Canada) annually. 3 Of the 27123 isolates, 3580 were from children ≤18 years of age, 12119 were from adults 19-64 years of age and 11424 were from elderly patients ≥65 years of age.
The CANWARD study receives annual approval by the University of Manitoba Research Ethics Board (H2009:059).
Antimicrobial susceptibility testing
The in vitro activity of selected antimicrobial agents was determined using custom-designed broth microdilution panels in accordance with CLSI guidelines. 8 Antimicrobial MICs were interpreted using CLSIestablished breakpoints. 9 As previously described, a mecA PCR was performed to confirm all methicillin-resistant Staphylococcus aureus (MRSA), the detection of the vanA and vanB genes by PCR confirmed potential vancomycin-resistant enterococci (VRE) and extended-spectrum b-lactamase (ESBL)-producing Escherichia coli were identified by performing the CLSI double-disc diffusion method on any isolates with a ceftriaxone and/or ceftazidime MIC of ≥1 mg/L. 3, 10, 11 MRSA molecular typing All MRSA were characterized using the staphylococcal protein A (spa) typing method and PFGE strain types were inferred from the spa type, as previously described. 12 Isolates with a spa type associated with the Canadian MRSA PFGE strain types (CMRSA)7 or CMRSA10 were considered community-associated MRSA (CA-MRSA). Isolates with a spa type associated with CMRSA1, CMRSA2, CMRSA4, CMRSA5, CMRSA3/6, CMRSA8 or CMRSA9 were considered hospital-associated MRSA (HA-MRSA).
Serotyping of Streptococcus pneumoniae
Serotyping of all S. pneumoniae isolates was performed using the Quellung reaction using type-specific antisera obtained from the Statens Serum Institute (Copenhagen, Denmark) 13 and supplementary molecular serotyping was performed using the CDC's PCR multiplex method (http:// www.cdc.gov/ncidod/biotech/strep/pcr.htm) at the National Microbiology Laboratory-Public Health Agency of Canada. 14 Isolates for which a serotype was not determined using PCR and a Quellung reaction was not observed were confirmed as S. pneumoniae by rpoB gene sequencing. 15 
Statistical analysis
A multifactorial logistic regression model was used to determine the impact of the study year, age group, gender, hospital location and specimen type on antimicrobial resistance using JMP w software version 10 (SAS Institute Inc., Cary, NC, USA). Second-degree interactions were evaluated and included in the model to account for possible interactions between variables. Stepwise regression was performed to identify relevant variables and interactions using a P value threshold of 0.10. P values ≤0.05 were considered statistically significant.
The differences in CA-MRSA and HA-MRSA rates in children and the elderly compared with the other age groups were assessed for statistical significance using the x 2 test.
Results and discussion
Predominant pathogens by age group
The top five most common organisms in each age group are listed in Table 1 . S. aureus, E. coli, S. pneumoniae and Pseudomonas aeruginosa appeared in the top five organisms for all of the age groups, representing 49.8% -60.6% of all pathogens. The predominance of these pathogens has been previously reported in other large surveillance studies. 16, 17 The specific rank order and the overall percentage of organisms per age group were most similar for children and adults. For children, Staphylococcus epidermidis was the fifth most common pathogen. Klebsiella pneumoniae was one of the top five pathogens for individuals ≥19 years of age. It was the seventh most common pathogen in children. In addition to these top five pathogens, other common pathogens included Haemophilus influenzae (rank order for children, adults and the elderly was 6, 7 and 8, respectively), Enterobacter cloacae (rank order for children, adults and the elderly was 9, 10 and 10, respectively) and Enterococcus faecalis (rank order was 9 for adults, 7 for the elderly and it did not rank in the top 10 organisms for children). Table 2 .
The proportions of S. aureus from children, adults and the elderly that were methicillin resistant were 11.2% (76/679), 22 .8% (624/2741) and 28.0% (566/2023), respectively. The proportions of E. coli from the corresponding patient groups that produced ESBLs were 1.0% (6/596), 4.3% (96/2224) and 4.9% (129/2631), while the corresponding proportions of enterococci that were VRE were 0.7% (1/153), 4.6% (30/648) and 3.8% (30/798). The occurrence of antibiotic-resistant organisms, including MRSA, VRE and ESBL-positive E. coli, was highest in the adult and elderly populations, which is consistent with previously reported findings. 5 Denkinger et al. 5 proposed a number of explanations for the high rate of multidrug resistance among the elderly, including higher use of antimicrobial agents, the increased exposure to antimicrobial resistant organisms in longterm care facilities and frequent hospitalizations.
S. aureus by age group
As detailed in Table 2 , methicillin-susceptible S. aureus had high susceptibility rates (.90%) to the majority of tested antimicrobial agents, regardless of age group. Conversely, MRSA demonstrated reduced susceptibility to the majority of the tested antimicrobial agents and the susceptibility rates were lowest in the elderly. The high susceptibility rates noted for methicillinsusceptible S. aureus and the reduced susceptibility observed with MRSA isolates are consistent with the current literature. 3, 18 All S. aureus were uniformly susceptible to daptomycin and linezolid, which has been observed in other recent surveillance studies conducted worldwide. 18 -22 Only one vancomycin-intermediate S. aureus isolate was identified in this study.
Among all S. aureus, methicillin resistance was significantly less frequently observed in children than in the other age groups (P,0.001). Additionally, methicillin resistance was less common among the adults as compared with the elderly (P,0.001). Similarly to the CANWARD study, Denkinger et al. 5 reported that MRSA rates in the elderly were twice as high as the rates in younger individuals ,65 years of age. Reported MRSA rates vary significantly by age group and by region of study. 5, 16, 19, 22 Clindamycin resistance in S. aureus was observed less frequently in children than in adults (P,0.001) and more frequently in the elderly than in the other age groups (P,0.001). Clarithromycin resistance was observed less frequently both in children than in the other age groups (P,0.001) and in the adults than in the elderly (P,0.001). Similarly, resistance to trimethoprim/sulfamethoxazole was seen less frequently in children than in the other age groups (P¼ 0.004). These observations demonstrating lower resistance among children may be explained by the distribution of CA-MRSA and HA-MRSA in the study age groups. CA-MRSA isolates have been shown to have greater susceptibility to many non-b-lactam antimicrobial agents, including clindamycin, erythromycin and trimethoprim/sulfamethoxazole, than HA-MRSA isolates. 10, 21 Of the 1266 MRSA in this study, 366 were designated as CA-MRSA, 868 were HA-MRSA and 32 were unique. The proportion of MRSA isolates that comprised CA-MRSA was higher in children as compared with the other age groups (P,0.001), with CA-MRSA accounting for 75.0%, 41.3% and 9.0% of the MRSA from children, adults and the elderly, respectively. The corresponding proportions of MRSA isolates from the three patient-age groups that were designated as HA-MRSA were 13.2%, 55.9% and 89.9%, respectively. HA-MRSA was significantly more frequently observed among the elderly than in the other age groups (P,0.001). A complete assessment of the MRSA in CANWARD has been performed by Nichol et al. 10 and is included in this Supplement.
E. coli by age group
E. coli demonstrated high susceptibility rates (.90%) for the majority of tested antimicrobials in all age groups ( Table 2 ). The susceptibility rates reported for E. coli isolated as part of the CANWARD study are consistent with those in the literature. 7,16 -18,20 Resistance rates .15% were observed only with cefazolin, ciprofloxacin, levofloxacin and trimethoprim/sulfamethoxazole, with some variation noted between the age groups. Cefazolin resistance was significantly higher among the elderly than in the other age groups (P ¼ 0.02); however, this may not be biologically relevant, as the resistance rates observed in adults (16.6%) and the elderly (17.1%) were similar. Ceftriaxone, ciprofloxacin and gentamicin resistance rates were lowest in children compared with the other age groups (P,0.001). Additionally, ciprofloxacin resistance was higher in the elderly compared with adults (P,0.001). The association between increasing age and increased resistance in E. coli has been reported previously. 7 The proportion of E. coli that produced ESBLs varied from 1% to 5% depending on the age group, with the lowest rates observed in children. This observation is supported by the literature, as ESBL rates in E. coli from North America have recently been reported as ,6% overall 18,20 and 1.9% in children. 16 An in-depth analysis of ESBL-producing E. coli from CANWARD has been included in this Supplement. 11
S. pneumoniae by age group
The S. pneumoniae were predominantly isolated from blood cultures and respiratory specimens. The number of S. pneumoniae isolated from blood cultures by age group was 127 (43.6%), 327 (33.8%) and 189 (30.3%) for children, adults and the elderly, respectively. The number of S. pneumoniae isolated from respiratory specimens by age group was 160 (55.0%), 634 (65.6%) and 434 (69.7%) for children, adults and the elderly, respectively.
S. pneumoniae demonstrated high susceptibility rates (.90%) for the majority of tested antimicrobials in all age groups ( Table 2 ). Based on the CLSI non-meningitis breakpoints for penicillin, high susceptibility rates were observed (97.5% -98.8%, depending on the age group). High susceptibility rates have been previously reported for Canadian S. pneumoniae isolates. 23, 24 Lower susceptibility rates were noted for clarithromycin (79.2% -81.6%, depending on the age group), penicillin with the CLSI oral and meningitis breakpoints (79.9% -82.3%, depending on the age group) and trimethoprim/sulfamethoxazole (83.8% -86.7%, depending on the age group). Similar Antimicrobial resistance in CANWARD by age group i33 JAC observations were recently reported for isolates collected around the world, with some of the lowest susceptibility rates observed with the macrolides, clindamycin, tetracycline, trimethoprim/ sulfamethoxazole and penicillin. 16, 18, 19, 22 However, considerable regional variability in susceptibility results has been reported. 16, 18 S. pneumoniae isolates with penicillin MICs .1 mg/L were identified significantly more frequently from children than the older age groups (P ¼0.03). The association between b-lactam resistance and age ,5 years has been well established. 4 Trimethoprim/sulfamethoxazole-resistant S. pneumoniae were less commonly isolated from the elderly than the other age groups (P ¼0.05). S. pneumoniae was uniformly susceptible to linezolid and vancomycin in all age groups. The universal susceptibility of S. pneumoniae to vancomycin has been consistently reported in the literature. 16,19,22 -24 
S. pneumoniae serotypes
The distribution of pneumococcal serotypes varied with patient age. In children, the most common serotypes (n/%) were 19A (42/19.3%), 15B (14/6.4%), 19F (13/6.0%), 3 (12/5.5%) and 7F (11/5.1%). For adults, the most common serotypes were 19A (62/9.2%), 3 (48/7.1%), 22F (36/5.3%), 23A (30/4.4%) and 5 (29/4.3%). The predominant serotypes for the elderly were 3 (38/8.8%), 22F (32/7.4%), 19A (32/7.4%), non-typeable (22/5.1%) and 19F (21/4.9%). Although serotype 19A appeared in the top five serotypes for each age group, its prevalence among children was more than twice the rate observed in adults or the elderly. The variability in serotype distribution by age group 25, 26 and the predominance of serotype 19A in children is consistent with the current literature. 25, 27 The aforementioned association Antimicrobial resistance in CANWARD by age group i35 JAC with elevated penicillin MICs in children in this study may be explained by the high prevalence of serotypes 19A and 19F, which have been associated with decreased susceptibility to a variety of antimicrobial agents, including penicillin, 22 in this age group.
The serotype distribution will probably continue to evolve as the newer conjugate vaccines, which include serotype 19A, are increasingly used. Notably, non-typeable isolates were the fourth most common 'serotype' identified in the elderly population. Non-typeable isolates were much less frequently observed in the other age groups. Non-typeable isolates have been shown to be significantly more frequently isolated from respiratory specimens than blood culture isolates. 14 This observation may explain the high percentage of non-typeable isolates identified in the elderly in this study, as the percentage of specimens originating from respiratory samples was higher in this age group than in the children or adults.
P. aeruginosa by age group
The susceptibility rates of P. aeruginosa collected in CANWARD by age group are detailed in Table 2 . The antimicrobial agents demonstrating the highest susceptibility rates (range by age groups) were colistin (91.5% -93.5%), amikacin (84.8% -95.5%), ceftazidime (81.5% -85.1%), doripenem (79.7% -88.1%), meropenem (78.4% -87.1%) and piperacillin/tazobactam (82.6% -85.5%). Although these agents had the highest rates of susceptibility among all the agents tested, the rates of resistance nonetheless ranged from 0% to 14.4% as P. aeruginosa is naturally less susceptible to antimicrobials than some of the other organisms described in this study. Overall, these results are consistent with the current literature. 16 -18,20 However, the resistance rates observed for isolates from children were slightly higher than those previously reported 16 and lower for some agents, such as the carbapenems, compared with resistance rates reported specifically on isolates collected in intensive care units (ICUs). 17 Ciprofloxacin and levofloxacin resistance rates were lower in children compared with the elderly (P,0.001) and were higher in adults than for all other age groups (P,0.001), which has been previously described 16, 18 and may be associated with the limited use of fluoroquinolones in children. Gentamicin resistance was lower among the elderly than in the other age groups (P ¼ 0.095). Meropenem resistance was highest in adults compared with the other age groups (P,0.001).
Study limitations
This study has a number of limitations. Although specific instructions are provided to each of the centres participating in the study, the collection methods used at the originating sites cannot be controlled by the coordinating site. Accordingly, we cannot guarantee that all of the organisms were isolated from clinically significant samples. The demographic information received as part of the CANWARD study is limited. For example, previous antimicrobial usage and patient outcome data are not available. An assessment of the impact of previous antimicrobial use on the higher resistance rates noted in the older age groups for a number of pathogen -antimicrobial agent combinations could not be performed. Additionally, differences between the age groups for hospitalization-specific factors, such as length of stay and ICU admission, which may impact antimicrobial resistance rates, could not be assessed due to this data limitation.
Conclusions
In general, the assessment of antimicrobial susceptibility patterns in the CANWARD dataset by age group (children, adults and the elderly) revealed that resistance rates were often higher in the older age groups. However, considerable variability in age-specific resistance trends for different pathogen -antimicrobial agent combinations was noted. Specific age-group analyses are critical to the development of guidelines for empirical therapy recommendations, as important differences in antimicrobial susceptibility results were noted. Ongoing, large-scale surveillance studies are essential to the continued availability of current antimicrobial resistance data.
